Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-22-083242
Filing Date
2022-03-24
Accepted
2022-03-24 06:06:01
Documents
5
Period of Report
2022-03-24

Document Format Files

Seq Description Document Type Size
1 FORM 6-K d333146d6k.htm 6-K 363419
2 GRAPHIC g333146g04h85.jpg GRAPHIC 1885
3 GRAPHIC g333146g05p85.jpg GRAPHIC 4735
4 GRAPHIC g333146g91v02.jpg GRAPHIC 2825
5 GRAPHIC g333146g99w66.jpg GRAPHIC 2936
  Complete submission text file 0001193125-22-083242.txt   382195
Mailing Address THREE INTERNATIONAL TOWERS LEVEL 24, 300 BARANGAROO AVENUE SYDNEY NSW C3 2000
Business Address THREE INTERNATIONAL TOWERS LEVEL 24, 300 BARANGAROO AVENUE SYDNEY NSW C3 2000 01161298780088
KAZIA THERAPEUTICS LTD (Filer) CIK: 0001075880 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 0630
Type: 6-K | Act: 34 | File No.: 000-29962 | Film No.: 22764621
SIC: 2834 Pharmaceutical Preparations